Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Sexually Transmitted Diseases

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    December 2011
  1. RODRIGUEZ AC , Schiffman M, Herrero R, Hildesheim A, et al
    Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.
    Int J Cancer. 2011 Dec 31. doi: 10.1002/ijc.27418.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  2. D'SOUZA G , Burk RD, Zhong Y, Minkoff H, et al
    Cervicovaginal HPV infection before and after hysterectomy: Evidence of different tissue tropism for oncogenic and non-oncogenic HPV types in a cohort of HIV-positive and HIV-negative women.
    Int J Cancer. 2011 Nov 28. doi: 10.1002/ijc.27363.
    PubMed     Text format     Related articles    Abstract available



  3. WANG Z , Sturgis EM, Zhang Y, Huang Z, et al
    Combined p53-related genetic variants together with HPV infection increase oral cancer risk.
    Int J Cancer. 2011 Nov 2. doi: 10.1002/ijc.27335.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  4. ATTNER P , Nasman A, Du J, Hammarstedt L, et al
    Survival in patients with human papillomavirus (HPV) positive tonsillar cancer in relation to treatment.
    Int J Cancer. 2011 Oct 31. doi: 10.1002/ijc.26490.
    PubMed     Text format     Related articles    Abstract available



  5. SETHI S , Ali-Fehmi R, Franceschi S, Struijk L, et al
    Characteristics and survival of head and neck cancer by HPV status: A cancer registry-based study.
    Int J Cancer. 2011 Oct 23. doi: 10.1002/ijc.26500.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  6. SZAREWSKI A , Poppe W, Skinner S, Wheeler C, et al
    Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18.
    Int J Cancer. 2011 Aug 19. doi: 10.1002/ijc.26362.
    PubMed     Text format     Related articles    Abstract available



  7. KREIMER AR , Schiffman M, Herrero R, Hildesheim A, et al
    Long-term risk of recurrent cervical HPV infection and precancer and cancer following excisional treatment.
    Int J Cancer. 2011 Aug 5. doi: 10.1002/ijc.26349.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  8. EIJSINK1 JJ , Lendvai1 A, Deregowski V, Klip1 HG, et al
    A four gene methylation marker panel as triage test in hr-HPV positive patients.
    Int J Cancer. 2011 Jul 27. doi: 10.1002/ijc.26326.
    PubMed     Text format     Related articles    Abstract available



  9. CERUTTI ML , Alonso LG, Tatti S, Prat-Gay GD, et al
    Long-lasting immunoprotective and therapeutic effects of a hyperstable E7 oligomer based vaccine in a murine HPV tumor model.
    Int J Cancer. 2011 Jul 21. doi: 10.1002/ijc.26294.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  10. CAMPOS NG , Kim JJ, Castle PE, Ortendahl JD, et al
    Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa.
    Int J Cancer. 2011 Jun 29. doi: 10.1002/ijc.26269.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  11. KAMINAGAKURA E , Villa LL, Andreoli MA, Simao J, et al
    High-risk HPV in oral squamous cell carcinoma of young patients.
    Int J Cancer. 2011 May 26. doi: 10.1002/ijc.26185.
    PubMed     Text format     Related articles    Abstract available



  12. VAN MONSJOU H , van Velthuysen M, van den Brekel M, Jordanova E, et al
    HPV status in young HNSCC patients.
    Int J Cancer. 2011 May 23. doi: 10.1002/ijc.26195.
    PubMed     Text format     Related articles    Abstract available



  13. PORRAS C , Wentzensen N, Rodriguez AC, Morales J, et al
    Switch from cytology-based to HPV-based cervical screening: Implications for colposcopy.
    Int J Cancer. 2011 May 23. doi: 10.1002/ijc.26194.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  14. GIORGI-ROSSI P , Franceschi S, Ronco G
    Human papillomavirus (HPV) prevalence and accuracy of HPV testing to detect high-grade cervical intraepithelial neoplasia.
    Int J Cancer. 2011 Apr 25. doi: 10.1002/ijc.26147.
    PubMed     Text format     Related articles   



    March 2011
  15. RIJKAART DC , Berkhof J, van Kemenade FJ, Coupe VM, et al
    Evaluation of 14 triage strategies for HPV DNA positive women in population-based cervical screening.
    Int J Cancer. 2011 Mar 11. doi: 10.1002/ijc.26056.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  16. GRAVITT PE , Belinson JL, Salmeron J, Shah KV, et al
    Looking ahead: A case for HPV testing of self-sampled vaginal specimens as a cervical cancer screening strategy.
    Int J Cancer. 2011 Feb 3. doi: 10.1002/ijc.25974.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  17. OOSTERHUIS K , Ohlschlager P, van den Berg JH, Toebes M, et al
    Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7.
    Int J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  18. PETAJA T , Pedersen C, Poder A, Strauss G, et al
    Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  19. ROTNAGLOVA E , Tachezy R, Salakova M, Prochazka B, et al
    HPV involvement in tonsillar cancer: Prognostic significance and clinically relevant markers.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  20. OVERMEER RM , Louwers JA, Meijer CJ, van Kemenade FJ, et al
    Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  21. TERLOU A , Seters M, Kleinjan A, Heijmans-Antonissen C, et al
    Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia.
    Int J Cancer. 2010;127:2831-40.
    PubMed     Text format     Related articles    Abstract available



  22. WANG X , Meyers C, Guo M, Zheng ZM, et al
    Up-regulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  23. HEYMANS J , Benoy IH, Poppe W, Depuydt CE, et al
    Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  24. TAYLOR S , Wang C, Wright TC, Denny L, et al
    A comparison of HPV testing of clinician-collected and self-collected samples during follow-up after screen-and-treat.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  25. MERIKUKKA M , Kaasila M, Namujju PB, Palmroth J, et al
    Differences in incidence and co-occurrence of vaccine and non-vaccine human papillomavirus (HPV) types in Finnish population before HPV mass vaccination suggest competitive advantage for HPV33.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  26. MARKS M , Gravitt P, Gupta S, Liaw K, et al
    The association of hormonal contraceptive use and HPV prevalence.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    April 2010
  27. HEUSINKVELD M , Welters MJ, van Poelgeest MI, van der Hulst JM, et al
    The detection of circulating Human Papillomavirus (HPV)-specific T cells is associated with improved survival of patients with deeply infiltrating tumors.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  28. OHLSCHLAGER P , Spies E, Alvarez G, Quetting M, et al
    The combination of TLR-9 adjuvantation and electroporation mediated delivery enhances in vivo anti-tumor responses after vaccination with HPV-16 E7 encoding DNA.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  29. TERLOU A , van Seters M, Kleinjan A, Heijmans-Antonissen C, et al
    Imiquimod induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  30. BERKHOF J , Coupe VM, Bogaards JA, van Kemenade FJ, et al
    The health and economic effects of HPV DNA screening in the netherlands.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  31. MOSCICKI AB , Widdice L, Ma Y, Farhat S, et al
    Comparison of natural histories of human papillomavirus (HPV) detected by clinician- and self- sampling.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  32. DARVAS K , Rosenberger S, Brenner D, Fritsch C, et al
    Histone deacetylase inhibitor-induced sensitization to TNFalpha/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression.
    Int J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: